Olympus Announces FDA Clearance of RenaFlex™, Its First Single-use Flexible Ureteroscope
Posted:
Olympus Corporation single-use flexible ureteroscopy system, RenaFlex™, has received clearance from the U.S. Food and Drug Administration (FDA) and will soon be available in the United States.
This product assists in the diagnosis and treatment of urological conditions such as #Urolithiasis.
The patients who watched the personalized AI avatar videos showed better understanding of their treatment plan, a greater ability to engage with health care decisions, and reduced stress compared to those who watched the standard educational video.
Read more here.
Once cancer has begun to spread within the body (metastasise) it generally becomes harder to treat and survival rates are lower. The new research focuses on patients with oligometastatic breast cancer, meaning a few small secondary tumors have broken away…
Attendees
Sponsors and Exhibitors
Contact us